Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sumiko Hamamoto"'
Autor:
Yukiko Kanda, Koji Nakashima, Kohei Kaku, Tomohiko Kimura, Sumiko Hamamoto, Masashi Shimoda, Mitsuru Hashiramoto, Kazuhito Tawaramoto, Hidenori Hirukawa
Publikováno v:
The Journal of Nutritional Biochemistry. 26:219-226
To assess the molecular mechanisms by which dietary restriction preserves the β-cell mass and function in diabetic db/db mice. Male db/db mice were divided into two groups with or without diet restriction. Daily food intake of db/db mice was adjuste
Autor:
Masafumi Matsuda, Kohei Kaku, Masashi Shimoda, Shinji Kamei, Yukiko Kanda-Kimura, Fuminori Tatsumi, Atsushi Obata, Sumiko Hamamoto, Tomoatsu Mune, Tomohiko Kimura, Mitsuru Hashiramoto, Hideaki Kaneto, Kazuhito Tawaramoto
Publikováno v:
Endocrine Journal. 62:741-747
It is known that reactive oxygen species (ROS) are involved in the development of insulin resistance as well as pancreatic β-cell dysfunction both of which are often observed in type 2 diabetes. In this study, we evaluated the effects of azelnidipin
Autor:
Koji Nakashima, Kohei Kaku, Sumiko Hamamoto, Yukiko Kanda, Kazuhito Tawaramoto, Mitsuru Hashiramoto, Fumiko Kawasaki, Michihiro Matsuki, Masashi Shimoda
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism
Pioglitazone preserves pancreatic β-cell morphology and function in diabetic animal models. In this study, we investigated the molecular mechanisms by which pioglitazone protects β-cells in diabetic db/db mice. In addition to the morphological anal
Autor:
Mitsuru Hashiramoto, Michihiro Matsuki, Hideaki Kaneto, Kazuhito Tawaramoto, Sumiko Hamamoto, Masashi Shimoda, Shinji Kamei, Fumiko Kawasaki, Tomoatsu Mune, Yukiko Kanda-Kimura, Kohei Kaku
Publikováno v:
Diabetesmetabolism. 41(5)
Diabetes & Metabolism - In Press.Proof corrected by the author Available online since lundi 8 juin 2015
Autor:
Mitsuru Hashiramoto, Tomohiko Kimura, Kenji Kohara, Seizo Okauchi, Kohei Kaku, Atsushi Obata, Hideaki Kaneto, Kazuhito Tawaramoto, Sumiko Hamamoto, Hidenori Hirukawa, Masashi Shimoda
Publikováno v:
Molecular and cellular endocrinology. 413
We investigated the effects of long- and short-term treatment with pioglitazone (Pio) and/or alogliptin (Alo) on β-cells in diabetic db/db mice. Six-week-old male db/db mice received Pio (25 mg/kg, oral) and/or Alo (30 mg/kg, oral) for 4 weeks and f
Autor:
Sumiko Hamamoto, Tomohiko Kimura, Hideaki Kaneto, Kazuhito Tawaramoto, Hidenori Hirukawa, Kohei Kaku, Mitsuru Hashiramoto, Masashi Shimoda, Seizo Okauchi, Kenji Kohara
Publikováno v:
Molecular and cellular endocrinology. 400
The aim was to compare the protective effects of pioglitazone (PIO) and/or liraglutide (LIRA) on β-cells with the progression of diabetes. Male db/db mice were treated with PIO and/or LIRA for 2 weeks in an early and advanced stage. In an early stag
Autor:
Sumiko, Hamamoto, Kohei, Kaku
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 70
Autor:
Kenji Kohara, Sumiko Hamamoto, Yukiko Kanda, Fuminori Tatsumi, Mitsuru Hashiramoto, Masashi Shimoda, Kohei Kaku, Kazuhito Tawaramoto
Publikováno v:
Diabetes, Obesity & Metabolism
Aim We investigated the molecular mechanisms by which vildagliptin preserved pancreatic β cell mass and function. Methods Morphological, biochemical and gene expression profiles of the pancreatic islets were investigated in male KK-Ay-TaJcl(KK-Ay) a
Autor:
Kazuhito Tawaramoto, Koji Nakashima, Hidenori Hirukawa, Kohei Kaku, Masashi Shimoda, Fuminori Tatsumi, Yukiko Kanda, Sumiko Hamamoto
Publikováno v:
Molecular and cellular endocrinology. 349(2)
Based on the hypothesis that MIN6 cells could produce glucagon-like peptide-1 (GLP-1) to maintain cell survival, we analyzed the effects of GLP-1 receptor agonist, exendin-4 (Ex4), and antagonist, exendin-(9-39) (Ex9) on cell function and cell differ
Autor:
Yukiko Kanda, Sumiko Hamamoto, Kazuhito Tawaramoto, Kohei Kaku, Michihiro Matsuki, Mitsuru Hashiramoto, Masashi Shimoda
Publikováno v:
Diabetologia
Aims/hypothesis We investigated the molecular mechanism by which the human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells in diabetic db/db mice. Methods Male db/db and m/m mice aged 10 weeks received liraglutide or vehi